Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-07-23
2000-09-26
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514246, 544180, 544194, C07D48704, A61K 31505
Patent
active
061242896
ABSTRACT:
Corticotropin releasing factor (CRF) antagonists of formula I or II: ##STR1## and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivityassociated with psychopathological disturbance andstress.
REFERENCES:
patent: 3910907 (1975-10-01), O'Brien et al.
patent: 3920652 (1975-11-01), Springer et al.
patent: 3995039 (1976-11-01), Rooney et al.
patent: 4021556 (1977-05-01), Springer et al.
patent: 4567263 (1986-01-01), Eicken et al.
patent: 4892576 (1990-01-01), Kruger et al.
patent: 4990647 (1991-02-01), Himmler et al.
patent: 4997940 (1991-03-01), Vinogradoff et al.
patent: 5089499 (1992-02-01), Barker et al.
patent: 5137887 (1992-08-01), Hashimoto et al.
patent: 5397774 (1995-03-01), Nugent et al.
patent: 5428044 (1995-06-01), Bantick et al.
patent: 5463071 (1995-10-01), Himmelsbach et al.
patent: 5464847 (1995-11-01), Courtemanche et al.
patent: 5484760 (1996-01-01), Bussler et al.
patent: 5486531 (1996-01-01), Schonafinger et al.
patent: 5723608 (1998-03-01), Yuan
Corticotropin Releasing Factor: Basic and Clinical Studies of a Neuropeptide (De Souza, Nemeroff) pp. 221-224 (1990).
Comprehensive Organic Synthesis (Trost, Fleming) 3:481-520 (1991).
Comprehensive Organic Synthesis (Trost, Fleming) 7:762-769 (1991).
Remington's Pharmaceutical Sciences (Gennaro, ed.) 17.sup.th ed. pp. 1418-1419 (1985).
Arch. Pharm. (Weinheim) 320, 487-191 (1987).
Psychopharmacology (Britton, Lee, Koob) 94:306-311 (1988).
Life Sciences (Britton, Koob, Rivier, Vale) 31:363-367 (1982).
Bull. Soc. Chim. Belg. (Maquestiau, Taghret, Eynde) vol. 101/No. 2/1992.
Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide (De Souza, Nemeroff) 221-224 (No Year).
J. Med. Chem. (Senga, et al.) 25:243-249 (1982).
J. Med. Chem. (Senga, et al.) 25:243-249 (1982).
Synapse (Battaglia, Webster, De Souza) 1:572-581 (1987).
Science (Nemeroff, et al.) 226:1342 (1984).
Brian Research Reviews (Dunn, Berridge) 15:71-100 (1990).
Proc. Natl. Acad. Sci. (Rivier, Spiess, Vale) 80:4851-4855 (1983).
Recent Progress in Hormone Research (Vale, et al.) 39:245-271 (1983).
Journal of Neuroscience (De Souza, et al.) vol. 5, No. 12, pp. 3189-3203.
Perspectives on Behavioral Medicine (Koob) 2:39-52 (1985).
Biol. Psychiatry (France, et al.) 23:86-88 (1988).
Hormones and Behavior (Berridge, Dunn) 21:393-401 (1987).
Hospital Practice (De Souza) pp. 59-71 (1988).
Arch. Gen. Psychiatry (Sapolsky) 46:1047-1051 (1989).
Psychopharmacology (Britton, et al.) 86:170-174 (1985).
Biol. Psychiatry (Arato, et al.) 25:355-359 (1989).
Regulatory Peptides (Berridge, Dunn) 16:83-93 (1986).
Neuropsychopharmacology (Grigoriadis, et al.) vol. 2, No. 1, pp. 53-60 (1989).
Psychopharmacology (Swerdlow, Geyer, Vale, Koob) 88:147-152 (1986).
Am. J. Psychiatry (Banki, et al.) 144:873-877 (1987).
Arch. Gen. Psychiatry (Nemeroff, et al.) 45:577-579 (1988).
New Eng. J. Med. (Gold, et al.) vol. 314, No. 21, pp. 1329-1335 (1986).
Life Sciences (Morley, et al.) 41:527-544 (1987).
Physiological Reviews (Blalock) vol. 69, No. 1, pp. 1-33 (1989).
Journal f. prakt. Chemie. (Joshi, Dubey) Band 321, Heft 2, pp. 341-344 (1979).
Journal of Medicinal Chemistry (Springer, et al.) vol. 19, No. 2, pp. 291-296 (1976).
J. Heterocyclic Chem. (O'Brien, et al.) 22:601-634 (1985).
J. Med. Chem. (Senga, Novinson, Wilson) 24:610-613 (1981).
Science (Vale, et al.) 213:1394-1397 (1981).
Chemical Abstracts, vol. 67, No. 28, 1967, abstract # 108663r.
Chemical Abstracts, vol. 74, No. 28, 1971, abstract # 22867t.
Chemical Abstracts, vol. 74, No. 28, 1971, abstract # 22872r.
Chemical Abstracts, vol. 68, No. 28, 1968, abstract # 114635v.
Arvanitis Argyrios Georgios
Chorvat Robert John
Gilligan Paul Joseph
He Liqi
Dupont Pharmaceuticals Co.
Ford John M.
O'Brien Maureen
Rubin Kenneth B.
LandOfFree
Azolo triazines and pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azolo triazines and pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azolo triazines and pyrimidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2100391